Inability to Tolerate Standard Therapy Is a Major Reason for Poor Outcome In Older Adults with Acute Lymphoblastic Leukemia (ALL): Results From the International MRC/ECOG Trial
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Conference item |
Published: |
2010
|
Search Result 1
Search Result 2